Skip Navigation


Hum. Reprod. Advance Access originally published online on April 4, 2006
Human Reproduction 2006 21(10):2467-2473; doi:10.1093/humrep/del076
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/10/2467    most recent
del076v3
del076v2
del076v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pagnamenta, A. T.
Right arrow Articles by Rahman, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pagnamenta, A. T.
Right arrow Articles by Rahman, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Dominant inheritance of premature ovarian failure associated with mutant mitochondrial DNA polymerase gamma

Alistair T. Pagnamenta1, Jan-Willem Taanman2, Callum J. Wilson3, Neil E. Anderson3, Rosetta Marotta4, Andrew J. Duncan1, Maria Bitner- Glindzicz5, Robert W. Taylor6, Adrienne Laskowski7, David R. Thorburn7 and Shamima Rahman1,8

1 Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, London, WC1N 1EH, UK 2 University Department of Clinical Neurosciences, Royal Free and University College Medical School, NW3 2PF, London, UK 3 Department of Neurology, Auckland City Hospital, Private Bag 92024, Auckland, New Zealand 4 Centre for Clinical Neurosciences and Neurological Research, St Vincent’s Hospital, Melbourne, VIC 3065, Australia 5 Clinical and Molecular Genetics Unit, Institute of Child Health, Guilford St., London, WC1N 1EH, UK 6 Mitochondrial Research Group, University of Newcastle upon Tyne, Newcastle, NE2 4HH, UK 7 Murdoch Children’s Research Institute, Royal Children’s Hospital and Department of Paediatrics, University of Melbourne, Melbourne, VIC 3052, Australia

8 To whom correspondence should be addressed at: Biochemistry, Endocrinology and Metabolism Unit, Institute of Child Health, London WC1N 1EH, UK. E-mail: s.rahman{at}ich.ucl.ac.uk

BACKGROUND: Premature ovarian failure (POF) results in menopause before the age of 40. Recently, mutations in the catalytic subunit of mitochondrial DNA polymerase gamma (POLG) were shown to segregate with POF in families with progressive external ophthalmoplegia (PEO) and multiple large-scale rearrangements of mitochondrial DNA (mtDNA). METHODS AND RESULTS: A patient, mother and maternal grandmother are described, all presenting with POF and PEO. The mother developed parkinsonism in her sixth decade. Normal mtDNA sequence excluded mitochondrial inheritance. Sequence analysis of polymerase gamma revealed a dominant Y955C mutation that segregated with disease. Southern blot analysis demonstrated mtDNA depletion in fibroblasts (43% of controls). In contrast, multiple rearrangements of mtDNA were seen in skeletal muscle, consistent with the relative sparing of nuclear-encoded complex II activity compared with other respiratory chain enzymes. Immunoblotting of native gels showed that DNA polymerase gamma stability was not affected, whereas a reverse-transcriptase primer-extension assay suggested a trend towards reduced polymerase activity in fibroblasts. CONCLUSIONS: This study confirms that POLG mutations can segregate with POF and parkinsonism and demonstrates for the first time that the Y955C mutation can lead to mtDNA depletion. Future screening projects will determine the frequency with which POLG is involved in the aetiology of POF and its impact on reproductive counselling.

Key words: mitochondrial DNA depletion/parkinsonism/PEO/POLG/premature menopause


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Med. Genet.Home page
M J Blok, B J van den Bosch, E Jongen, A Hendrickx, C E de Die-Smulders, J E Hoogendijk, E Brusse, M de Visser, B T Poll-The, J Bierau, et al.
The unfolding clinical spectrum of POLG mutations
J. Med. Genet., November 1, 2009; 46(11): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. A. Graziewicz, R. J. Bienstock, and W. C. Copeland
The DNA polymerase {gamma} Y955C disease variant associated with PEO and parkinsonism mediates the incorporation and translesion synthesis opposite 7,8-dihydro-8-oxo-2'-deoxyguanosine
Hum. Mol. Genet., November 15, 2007; 16(22): 2729 - 2739.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.